Quadrant Group Plc - Re Judgement Appeal

RNS No 2984w
QUADRANT HEALTHCARE PLC
18th January 1999

                                       
                        Patent Judgement Appeal Lodged

Following the announcement on 27 November 1998 concerning the judgement given
by Mr. Justice Pumfrey in respect of litigation commenced by Quadrant Holdings
Cambridge Limited ("QHCL") and Quadrant Bioresources Limited ("QBL"), both
wholly owned subsidiaries of Quadrant, against Dr. Bruce Roser and certain
companies controlled by or associated with him, Quadrant are able to confirm
that costs of #460,000 were subsequently awarded against Dr. Roser and the
other defendants.  Notwithstanding that it has been claimed by the defendants
that they are unable to meet this costs order, Quadrant intends fully to
pursue all rights of recourse against them.

Quadrant has recently been advised that the defendants have appealed against
the costs award and certain aspects of the judgement being those relating to
the termination of the agreement between QHCL and Quadrant Research
Foundation, infringement of the base patent and the ownership of the patent
applications filed by the defendants after Dr. Roser was dismissed from
Quadrant.

It should be noted that the validity of Quadrant's base patent and the order
requiring Dr. Roser to execute certain documentation in connection with the
prosecution of Quadrant's patents have not been challenged in this appeal.

Commenting on today's announcement, Iain Ross, Chief Executive of Quadrant,
said:

"We have every confidence that this appeal will be dismissed and have been
informed by our lawyers that the amount of management time required to defend
the appeal will be limited."

Enquiries:

Quadrant Healthcare plc                 Tel:  [phone]
Iain Ross, Chief Executive
Raj Uppal, Finance Director

Gavin Anderson & Company                Tel:  [phone]
David Yates / Jane McLeod-Scott


END

MSCKLGMMZRGLLMM